Zevra Therapeutics
ZVRA
ZVRA
93 hedge funds and large institutions have $78.6M invested in Zevra Therapeutics in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.05% more ownership
Funds ownership: 34.29% → 38.33% (+4%)
3% less capital invested
Capital invested by funds: $80.7M → $78.6M (-$2.12M)
Holders
93
Holding in Top 10
–
Calls
$985K
Puts
$300K
Top Buyers
| 1 | +$4.02M | |
| 2 | +$1.47M | |
| 3 | +$1.24M | |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$890K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$676K |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$749K | |
| 3 | -$527K | |
| 4 |
Renaissance Technologies
New York
|
-$209K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$166K |